One-pot recombinase polymerase amplification and CRISPR/Cas12a assay for Cryptococcus neoformans
Applied Microbiology and Biotechnology · 2026
DOI: 10.1007/s00253-026-13733-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2026. Verfasst von Zixin Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yuebei People's Hospital, Shantou University Medical College, No 133, Huimin Road South, Wujiang District, Shaogua…. Hauptthemen laut MEDLINE: Cryptococcus neoformans, CRISPR-Cas Systems, Recombinases, Cryptococcosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cryptococcus neoformans, an opportunistic fungal pathogen, can induce central nervous system infections, posing a life-threatening risk and imposing substantial global health challenges and economic burdens. Given the significant reduction in mortality achieved through early monitoring of C. neoformans, there is an urgent demand for a rapid detection method for this pathogen. Herein, we developed a rapid, sensitive, and specific assay for the detection of C. neoformans based on a one-pot recombinase polymerase amplification (RPA) and CRISPR/Cas12a system, which can be read using a real-time fluorescent PCR instrument or lateral flow strips. This assay exhibits high sensitivity, with a detection limit of 1 copy/µL for C. neoformans, and no cross-reactivity was observed across different fungal strains. Notably, the assay can be performed in harsh environments without reliance on complex equipment, making it suitable for point-of-care testing (POCT). Collectively, this method not only provides a robust alternative for C. neoformans detection but also offers valuable insights for the identification of other fungal pathogens. KEY POINTS: • We developed a one-pot RPA and CRISPR/Cas12a assay to detect Cryptococcus neoformans. • This assay exhibits high sensitivity and specificity. • Detection results can be obtained by three ways which is suitable for POCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Yuebei People's Hospital, Shantou University Medical College, No 133, Huimin Road South, Wujiang District, Shaoguan, 512025, China.
- Laboratory for Diagnosis of Clinical Microbiology and Infection, Yuebei People's Hospital, Shantou University Medical College, Shaoguan, 512025, China.
- Research Center for Interdisciplinary & High-Quality Innovative Development in Laboratory Medicine, Shaoguan, 512025, China.
- Shaoguan Municipal Quality Control Center for Laboratory Medicine, Yuebei People's Hospital, Shantou University Medical College, Shaoguan, 512025, China.
- Shaoguan Municipal Quality Control Center for Surveillance of Bacterial Resistance, Shaoguan, 512025, China.
- Shaoguan Engineering Research Center for Research and Development of Molecular and Cellular Technology in Rapid Diagnosis of Infectious Diseases and Cancer, Shaoguan, 512025, China.
Zitieren
APA
Li, Z., Chen, L., Luo, J., Lu, Y., Zhang, H., & Zhao, P. (2026). One-pot recombinase polymerase amplification and CRISPR/Cas12a assay for Cryptococcus neoformans. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-026-13733-0
Vancouver
Li Z, Chen L, Luo J, Lu Y, Zhang H, Zhao P. One-pot recombinase polymerase amplification and CRISPR/Cas12a assay for Cryptococcus neoformans. Applied Microbiology and Biotechnology. 2026. doi:10.1007/s00253-026-13733-0
BibTeX
@article{Li2026,
author = {Li, Zixin and Chen, Lei and Luo, Jun and Lu, Yamin and Zhang, Helin and Zhao, Pingsen},
title = {One-pot recombinase polymerase amplification and CRISPR/Cas12a assay for Cryptococcus neoformans},
journal = {Applied Microbiology and Biotechnology},
year = {2026},
doi = {10.1007/s00253-026-13733-0}
}
EUVIMED